Biorem Inc(TSE:BRM)
CA$4.60+0.04 (+0.88%)
TSE:BRM
Biorem Inc financials statements
CA$4.60
At close:+0.04 (+0.88%)
Want to see TSE:BRM full AI Analyst Report?
Biorem Inc (BRM) Ratios
21 Followers
Biorem Inc Ratios
TSE:BRM's free cash flow for Q3 2026 was C$942.01K. For the 2026 fiscal year, TSE:BRM's free cash flow was decreased by C$-113.13K and operating cash flow was C$1.06M. See a summary of the company’s cash flow.
| Ratios | Mar 26 | Mar 25 | Mar 24 | Mar 23 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 1.85 | 1.63 | 1.48 | 1.38 | 1.22 |
| Quick Ratio | 1.77 | 1.44 | 1.42 | 1.31 | 1.15 |
| Cash Ratio | 0.70 | 0.35 | 0.16 | 0.29 | 0.34 |
| Solvency Ratio | 0.28 | 0.20 | 0.15 | 0.12 | 0.10 |
| Operating Cash Flow Ratio | 0.46 | 0.25 | 0.04 | 0.11 | 0.29 |
| Short-Term Operating Cash Flow Coverage | 12.86 | 6.46 | 0.90 | 1.11 | 2.51 |
| Net Current Asset Value | C$ 11.90M | C$ 6.64M | C$ 3.25M | C$ 1.57M | C$ -1.04M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.08 | 0.12 | 0.17 | 0.23 | 0.30 |
| Debt-to-Equity Ratio | 0.19 | 0.33 | 0.62 | 1.05 | 2.88 |
| Debt-to-Capital Ratio | 0.16 | 0.25 | 0.38 | 0.51 | 0.74 |
| Long-Term Debt-to-Capital Ratio | 0.08 | 0.15 | 0.27 | 0.40 | 0.64 |
| Financial Leverage Ratio | 2.25 | 2.68 | 3.58 | 4.59 | 9.76 |
| Debt Service Coverage Ratio | 7.32 | 4.85 | 3.45 | 1.43 | 1.26 |
| Interest Coverage Ratio | 40.59 | 22.22 | 11.20 | 10.27 | 57.73 |
| Debt to Market Cap | 0.04 | 0.05 | 0.19 | 0.31 | 0.15 |
| Interest Debt Per Share | 0.19 | 0.24 | 0.28 | 0.32 | 0.16 |
| Net Debt to EBITDA | -1.23 | -0.34 | 0.55 | 0.32 | 0.45 |
| Profitability Margins | |||||
| Gross Profit Margin | 29.72% | 26.87% | 27.90% | 30.36% | 25.48% |
| EBIT Margin | 15.52% | 11.61% | 12.17% | 9.15% | 9.53% |
| EBITDA Margin | 16.63% | 12.87% | 13.69% | 10.36% | 10.94% |
| Operating Profit Margin | 15.52% | 11.61% | 12.17% | 9.15% | 8.46% |
| Pretax Profit Margin | 14.94% | 11.09% | 11.08% | 8.26% | 8.31% |
| Net Profit Margin | 11.37% | 8.13% | 8.66% | 5.59% | 5.30% |
| Continuous Operations Profit Margin | 11.37% | 8.13% | 8.66% | 5.59% | 5.30% |
| Net Income Per EBT | 76.11% | 73.37% | 78.14% | 67.68% | 63.77% |
| EBT Per EBIT | 96.26% | 95.50% | 91.07% | 90.26% | 98.27% |
| Return on Assets (ROA) | 14.35% | 10.68% | 9.05% | 7.78% | 6.77% |
| Return on Equity (ROE) | 32.27% | 28.65% | 32.43% | 35.68% | 66.05% |
| Return on Capital Employed (ROCE) | 38.49% | 32.20% | 30.08% | 33.82% | 34.88% |
| Return on Invested Capital (ROIC) | 28.18% | 22.47% | 21.94% | 19.29% | 17.30% |
| Return on Tangible Assets | 14.35% | 10.68% | 9.05% | 7.78% | 6.77% |
| Earnings Yield | 11.13% | 6.33% | 13.91% | 11.84% | 4.01% |
| Efficiency Ratios | |||||
| Receivables Turnover | 2.79 | 2.52 | 1.67 | 2.36 | 2.42 |
| Payables Turnover | 3.74 | 6.81 | 2.96 | 4.27 | 3.60 |
| Inventory Turnover | 21.75 | 9.42 | 20.13 | 22.64 | 20.23 |
| Fixed Asset Turnover | 23.18 | 18.52 | 12.64 | 28.40 | 21.38 |
| Asset Turnover | 1.26 | 1.31 | 1.05 | 1.39 | 1.28 |
| Working Capital Turnover Ratio | 3.60 | 4.62 | 4.35 | 7.41 | 3.66 |
| Cash Conversion Cycle | 50.22 | 130.13 | 113.40 | 85.38 | 67.78 |
| Days of Sales Outstanding | 130.96 | 145.03 | 218.72 | 154.80 | 151.11 |
| Days of Inventory Outstanding | 16.78 | 38.74 | 18.13 | 16.13 | 18.04 |
| Days of Payables Outstanding | 97.52 | 53.64 | 123.44 | 85.54 | 101.36 |
| Operating Cycle | 147.74 | 183.76 | 236.85 | 170.92 | 169.15 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | 0.48 | 0.23 | 0.03 | 0.09 | 0.11 |
| Free Cash Flow Per Share | 0.45 | 0.21 | -0.00 | 0.08 | 0.10 |
| Dividend Paid and CapEx Coverage Ratio | 20.77 | 9.91 | 0.89 | 7.11 | 49.77 |
| Capital Expenditure Coverage Ratio | 20.77 | 9.91 | 0.89 | 7.11 | 49.77 |
| Operating Cash Flow Coverage Ratio | 2.70 | 1.04 | 0.12 | 0.30 | 0.67 |
| Operating Cash Flow to Sales Ratio | 0.18 | 0.10 | 0.02 | 0.05 | 0.15 |
| Free Cash Flow Yield | 16.80% | 6.89% | -0.40% | 9.11% | 11.46% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | 9.00 | 15.80 | 7.19 | 8.45 | 24.92 |
| Price-to-Sales (P/S) Ratio | 1.02 | 1.28 | 0.62 | 0.47 | 1.32 |
| Price-to-Book (P/B) Ratio | 2.90 | 4.53 | 2.33 | 3.01 | 16.46 |
| Price-to-Free Cash Flow (P/FCF) Ratio | 5.95 | 14.51 | -249.41 | 10.97 | 8.72 |
| Price-to-Operating Cash Flow Ratio | 5.67 | 13.05 | 31.98 | 9.43 | 8.55 |
| Price-to-Earnings Growth (PEG) Ratio | 0.16 | 0.44 | 0.18 | 0.05 | -0.75 |
| Enterprise Value Multiple | 4.91 | 9.64 | 5.10 | 4.88 | 12.52 |
| Enterprise Value | 34.60M | 46.43M | 17.57M | 14.60M | 33.52M |
| EV to EBITDA | 4.91 | 9.64 | 5.10 | 4.88 | 12.52 |
| EV to Sales | 0.82 | 1.24 | 0.70 | 0.51 | 1.37 |
| EV to Free Cash Flow | 4.76 | 14.01 | -279.54 | 11.76 | 9.05 |
| EV to Operating Cash Flow | 4.53 | 12.60 | 35.85 | 10.10 | 8.86 |
| Tangible Book Value Per Share | 0.93 | 0.67 | 0.43 | 0.29 | 0.05 |
| Shareholders’ Equity Per Share | 0.93 | 0.67 | 0.43 | 0.29 | 0.05 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.24 | 0.27 | 0.22 | 0.32 | 0.36 |
| Revenue Per Share | 2.64 | 2.37 | 1.61 | 1.86 | 0.68 |
| Net Income Per Share | 0.30 | 0.19 | 0.14 | 0.10 | 0.04 |
| Tax Burden | 0.76 | 0.73 | 0.78 | 0.68 | 0.64 |
| Interest Burden | 0.96 | 0.96 | 0.91 | 0.90 | 0.87 |
| Research & Development to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A to Revenue | 0.15 | 0.15 | 0.06 | 0.11 | 0.07 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.01 | 0.00 | 0.00 |
| Income Quality | 1.59 | 1.21 | 0.22 | 0.90 | 2.92 |
Currency in CAD

